Literature DB >> 26094878

Functional insights from high resolution structures of mouse protein arginine methyltransferase 6.

Luc Bonnefond1, Johann Stojko2, Justine Mailliot1, Nathalie Troffer-Charlier1, Vincent Cura1, Jean-Marie Wurtz1, Sarah Cianférani2, Jean Cavarelli3.   

Abstract

PRMT6 is a protein arginine methyltransferase involved in transcriptional regulation, human immunodeficiency virus pathogenesis, DNA base excision repair, and cell cycle progression. Like other PRMTs, PRMT6 is overexpressed in several cancer types and is therefore considered as a potential anti-cancer drug target. In the present study, we described six crystal structures of PRMT6 from Mus musculus, solved and refined at 1.34 Å for the highest resolution structure. The crystal structures revealed that the folding of the helix αX is required to stabilize a productive active site before methylation of the bound peptide can occur. In the absence of cofactor, metal cations can be found in the catalytic pocket at the expected position of the guanidinium moiety of the target arginine substrate. Using mass spectrometry under native conditions, we show that PRMT6 dimer binds two cofactor and a single H4 peptide molecules. Finally, we characterized a new site of in vitro automethylation of mouse PRMT6 at position 7.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epigenetics; Methyltransferase; PRMT6; Protein structure; S-adenosyl-l-methionine

Mesh:

Substances:

Year:  2015        PMID: 26094878     DOI: 10.1016/j.jsb.2015.06.017

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  8 in total

1.  Structural basis of arginine asymmetrical dimethylation by PRMT6.

Authors:  Hong Wu; Weihong Zheng; Mohammad S Eram; Mynol Vhuiyan; Aiping Dong; Hong Zeng; Hao He; Peter Brown; Adam Frankel; Masoud Vedadi; Minkui Luo; Jinrong Min
Journal:  Biochem J       Date:  2016-08-01       Impact factor: 3.857

2.  Transition state mimics are valuable mechanistic probes for structural studies with the arginine methyltransferase CARM1.

Authors:  Matthijs J van Haren; Nils Marechal; Nathalie Troffer-Charlier; Agostino Cianciulli; Gianluca Sbardella; Jean Cavarelli; Nathaniel I Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-22       Impact factor: 11.205

3.  Hijacking DNA methyltransferase transition state analogues to produce chemical scaffolds for PRMT inhibitors.

Authors:  Ludovic Halby; Nils Marechal; Dany Pechalrieu; Vincent Cura; Don-Marc Franchini; Céline Faux; Fréderic Alby; Nathalie Troffer-Charlier; Srikanth Kudithipudi; Albert Jeltsch; Wahiba Aouadi; Etienne Decroly; Jean-Claude Guillemot; Patrick Page; Clotilde Ferroud; Luc Bonnefond; Dominique Guianvarc'h; Jean Cavarelli; Paola B Arimondo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-06-05       Impact factor: 6.237

4.  Transient Kinetics Define a Complete Kinetic Model for Protein Arginine Methyltransferase 1.

Authors:  Hao Hu; Cheng Luo; Y George Zheng
Journal:  J Biol Chem       Date:  2016-11-10       Impact factor: 5.157

5.  Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach.

Authors:  Giulia Iannelli; Ciro Milite; Nils Marechal; Vincent Cura; Luc Bonnefond; Nathalie Troffer-Charlier; Alessandra Feoli; Donatella Rescigno; Yalong Wang; Alessandra Cipriano; Monica Viviano; Mark T Bedford; Jean Cavarelli; Sabrina Castellano; Gianluca Sbardella
Journal:  J Med Chem       Date:  2022-04-28       Impact factor: 8.039

6.  Inverse Molecular Docking Elucidating the Anticarcinogenic Potential of the Hop Natural Product Xanthohumol and Its Metabolites.

Authors:  Katarina Kores; Zala Kolenc; Veronika Furlan; Urban Bren
Journal:  Foods       Date:  2022-04-26

7.  A First-in-Class, Highly Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 6.

Authors:  Yudao Shen; Fengling Li; Magdalena M Szewczyk; Levon Halabelian; Irene Chau; Mohammad S Eram; Carlo Dela Seña; Kwang-Su Park; Fanye Meng; He Chen; Hong Zeng; Aiping Dong; Hong Wu; Viacheslav V Trush; David McLeod; Carlos A Zepeda-Velázquez; Robert M Campbell; Mary M Mader; Brian M Watson; Matthieu Schapira; Cheryl H Arrowsmith; Rima Al-Awar; Dalia Barsyte-Lovejoy; H Ümit Kaniskan; Peter J Brown; Masoud Vedadi; Jian Jin
Journal:  J Med Chem       Date:  2021-02-16       Impact factor: 7.446

Review 8.  The Emerging Role of PRMT6 in Cancer.

Authors:  Zhixian Chen; Jianfeng Gan; Zhi Wei; Mo Zhang; Yan Du; Congjian Xu; Hongbo Zhao
Journal:  Front Oncol       Date:  2022-03-04       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.